1. Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha T, Bryson H, de Giralamo G, de Graaf R, Demyttenaere K, Gasquet I, Haro J, Katz S, Kessler R, Kovess V, Lepine J, Ormel J, Polidori G, Rousso J, Vilagut G (2004) Psychotropic drug utilization in Europe: results from the European study of the epistemology of mental disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):55–64
2. Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha T, Bryson H, de Giralamo G, de Graaf R, Demyttenaere K, Gasquet I, Haro J, Katz S, Kessler R, Kovess V, Lepine J, Ormel J, Polidori G, Rousso J, Vilagut G (2004) Use of mental health services in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):47–54
3. Andrews G, Sanderson K, Corry J, Lapsley H (2000) Using epidemiological data to model efficiency in reducing the burden of depression. J Ment Health Policy Econ 3:175–186
4. Bramesfeld A, Grobe T, Schwartz F (2007) Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data. Euro J Epidemiology DOI 10.1007/s10654-007-9128-z
5. Busch S, Leslie D, Rosenheck R (2004) Measuring quality of psychopharmacotherapy for depression in a national health care system. Med Care 42:532–542